AMRX - Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.09 revenue of $599M beats by $33.89M
2023-08-04 06:03:20 ET
- Amneal Pharmaceuticals press release ( NYSE: AMRX ): Q2 Non-GAAP EPS of $0.19 beats by $0.09 .
- Revenue of $599M (+7.2% Y/Y) beats by $33.89M .
- FY23 Outlook:
- Net revenue of $2.3B-$2.4B from prior guidance of $2.25-$2.35B
- Adj EPS of $0.45-$0.55 from prior guidance of $0.40-$0.50
For further details see:
Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.09, revenue of $599M beats by $33.89M